BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Sun Pharma to Invest ₹3,000 Crore in Madhya Pradesh Unit

Synopsis:


Sun Pharma approved a ₹3,000 crore investment to build a formulation manufacturing unit in Madhya Pradesh. The decision was recorded in the company’s exchange filing and outlines capital allocation for the upcoming facility without forward-looking statements.

Sun Pharmaceutical Industries Limited News Today

As quoted in the press release from Sun Pharma and its news (NSE Exchange Filings), Sun Pharma approved an investment plan of ₹3,000 crore to build a formulations manufacturing unit in Madhya Pradesh. The official filing stated the decision and listed the capital amount, the type of facility and the location. The update also noted that the approval followed the company’s regular governance process.

The statement outlined the plan in clear terms. It listed the proposed spend for construction, equipment and essential systems required for the unit. Sun Pharmaceutical Industries Limited and share price remains an important part of public updates, as such information is relevant for listed company disclosures. The filing did not include forward-looking points and stayed within confirmed facts.

Also read: Canara Bank Raises ₹3,500 Crore through AT1 Bonds at 7.55%

SUN PHARMACEUTICAL IND L

Trade

1787.1-12.40 (-0.68 %)

Updated - 03 December 2025
1816.00day high
DAY HIGH
1786.10day low
DAY LOW
314451
VOLUME (BSE)

Key Takeaways

  • Approved investment: ₹3,000 crore

  • Purpose: Formulations manufacturing unit

  • Location: Madhya Pradesh

  • Source: Exchange filing from Sun Pharma

Also read: KPI Green Energy Secures ₹489 Cr Floating Solar EPC Order

Overview of the Investment Approval

The filing confirmed that Sun Pharmaceutical Industries Limited approved ₹3,000 crore for a new formulation manufacturing unit. This approval was documented through a formal board decision. It recorded the use of funds for infrastructure, machinery and key systems needed for the unit.

The statement focused on the nature of the project. It explained that the investment will support work such as building structures, installing equipment and creating utility systems. Each detail in the update came from the formal filing. There were no extended comments or assumptions, and no links to future outcomes.

Project Structure and Operational Scope

The filing mentioned that the new unit will focus on formulations. It stated that the investment will cover setup activities needed to build a functional manufacturing facility. This includes site development, equipment installation and related technical systems.

The project description stayed limited to confirmed details. The document did not discuss production capacity or timelines. Instead, it kept the focus on the approval, the type of unit and the location. The communication explained the administrative nature of the decision. It reflected the company’s standard format for reporting large investments made through board approval.

Investment Summary Table

Particulars

Details

Approving Authority

Sun Pharma Board

Investment Value

₹3,000 crore

Project Type

Formulations Manufacturing Unit

Location

Madhya Pradesh

Source

Exchange Filing

Business Context

The filing recorded the capital allocation as part of routine business communication. It confirmed the investment without adding predictions or market views. The statement placed the project within the company’s usual manufacturing and operational plans. 

Sun Pharma Share Price Update

As on 02-Dec-2025 at 15:30 PM IST, Sun Pharmaceutical Industries Limited share price stood at ₹1,804.90, reflecting a movement of -₹2.50 (-0.14%). The session recorded a previous close of ₹1,807.40, an open of ₹1,804.00, a high of ₹1,814.90, and a low of ₹1,788.60. The VWAP stood at ₹1,797.04, and the close price was ₹1,799.50.

Published Date : 03 Dec 2025

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,600+ Cr MTF Book

icon-with-text